Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice

Neuropharmacology

Volumn 35, Issue 4, 1996, Pages 467-474

  Okuyama, S ^a   Imagawa, Y ^a   Tomisawa, K ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

clozapine; hyperlocomotion; MK 801; NE 100 (N,N dipropyl 2 4 methoxy 3 (2 phenylethoxy)phenyl ethylamine monohydrochloride; reserpine; sigma ligands; sulpiride

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; CLOZAPINE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTAZOCINE; PRECLAMOL; SIGMA OPIATE RECEPTOR; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029950687     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00193-X     Document Type: Article

References (29)

1. Berry S. C., Dawkins, S. L. and Lodge, D. (1984) Comparison of σ- and κ-opiate receptor ligands as excitatory amino acid antagonists. Br. J. Pharmacol. 83: 179-185.
2. Carlsson M. and Carlsson A. (1989a) The NMDA antagonist MK-801 caused marked locomotor stimulation in mono-amine-depleted mice. J. Neural Transm. 75: 221-226.
3. Carlsson M. and Carlsson A. (1989b) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J. Neural Transm. 77: 65-71.
4. Chaki S., Tanaka M., Muramatsu M. and Otomo S. (1994) NE-100, a novel potent σ-ligand, preferentially binds to σ-1 binding sites in guinea pig brain. Eur. J. Pharmacol. 251: R1-R2.
5. Church J. and Lodge D. (1990a) Failure of sigma-receptor ligands to reduce the excitatory actions of N-methyl-DL-aspartate on rat spinal neurons in vivo. J. Pharm. Pharmacol. 42: 56-57.
6. Church, J. and Lodge, D. (1990b) Cyclazocine and pentazocine as N-methyaspartate antagonists on cat and rat spinal neurons in vivo. J. Pharmacol. exp. Ther. 253: 636-645.
7. Deutsch S. I., Weizman A., Goldman M. E. and Morihisa J. M. (1988) The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. Clin. Neuropharmacol. 11: 105-119.
8. Fletcher E., Church J., Abdel-Hamid K. and MacDonald J. F. (1993) Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-toyl)guanidine in mouse and rat cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 109: 1196-1205.
9. 3H-glutamate binding. Soc. Neurosci. Abst. 18: 978.
10. Gao X.-M., Shirakawa O, Du F. and Tamminga C. A. (1993) Delayed regional metabolic action of phencyclidine. Eur. J. Pharmacol. 241: 7-15.
11. Hiramatsu M., Nabeshima T., Furukawa H. and Kameyama T. (1987) Different effects of ethylketocyclazocine on phencyclidine- and n-allylnormetazocine-induced stereo-typed behaviors in rats. Pharmacol. Biochem. Behav. 28: 489-494.
12. Itzhak Y. (1989) Multiple affinity binding sites of the σ-receptor: Effect of GTP-binding protein-modifying agents. Molec. Pharmacol. 36: 512-517.
13. 3H]-1-[1-(2-thienyl) cyclohexyl] piperidine. J. Pharmacol. exp. Ther. 238: 739-748.
14. Maurice T., Hiramatsu M., Itoh J., Kameyama T., Hasegawa T. and Nabeshima T. (1994) Behavioral evidence for a modulating role of σ-ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res. 647: 44-56.
15. Monnet F. P., Debonnel G. and De Montigny C. (1991) In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J. Pharmacol. exp. Ther. 261: 123-130.
16. Ogawa S., Okuyama S., Araki H., Nakazato A. and Otomo S. (1994a) A rat model of phencyclidine psychosis. Life Sci. 55: 1605-1610.
17. Ogawa S., Okuyama S., Araki H. and Otomo S. (1994b) Effect of NE-100, a novel σ-receptor ligand, on phencyclidine-induced cognitive dysfunction. Eur. J. Pharmacol. 263: 9-15.
18. Ogawa S., Okuyama S., Tsuchida K., Araki H. and Otomo S. (1995) The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model Gen. Pharmacol. 26: 177-182.
19. Okuyama S., Imagawa Y., Ogawa S., Araki H., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M. and Otomo S. (1993) NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 53: PL 285-290.
20. Okuyama S., Imagawa Y., Sakagawa T., Nakazato A., Yamagichi K., Katoh M., Yamada S., Araki H. and Otomo S. (1994) NE-100, a novel sigma receptor ligand: effect on phencyclidine-induced behaviors in rats, dogs and monkeys. Life Sci. 55: PL 133-138.
21. Okuyama S., Ogawa S., Nakazato A. and Tomizawa K. (1995) Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats. Neurosci. Lett. 189: 60-62.
22. Quirion R., Chicheportiche P. C., Contreras K. M., Johnson D., Lodge S., Tam W., Woods J. H. and Zukin S. R. (1987). Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Pharmacol. 10: 444-446.
23. Quirion R., Bowen W., Itzhak Y., Junien J. L., Musacchio J. M., Rothman R. B., Su T.-P., Tam S. W. and Taylor D. P. (1992) A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 13: 85-86.
24. Sanger D. L. and Joly, D. (1991) Effects of NMDA receptor antagonists and sigma ligands on the acquision of conditioned fear in mice. Psychopharmacology (Berlin) 104: 27-34.
25. Sunahara R. K., Seeman P., Van Tol H. H. M. and Niznik H. B. (1993) Dopamine receptor and antipsychotic drugs response. Br. J. Psychiatry 163 (suppl. 22): 31-38.
26. 3H]NE-100, a novel sigma-receptor ligand, to guinea pig brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 351: 244-251.
27. Toru M., Kurumaji A. and Ishimaru M. (1994) Excitatory amino acids: implications for psychiatric disorders research. Life Sci. 55: 1683-1699.
28. 3H]TCP binding to intact primary cultured neuronal cells. Life Sci. 56: 39-43.
29. Yamamoto H., Yamamoto T., Sagi N., Klenerova V., Kawai N., Baba A., Takamori E. and Moroji T. (1995) Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ site. J. Neurosci. 15: 731-736.